Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry
The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or...
Gespeichert in:
Veröffentlicht in: | Chemical reviews 2016-12, Vol.116 (24), p.15235-15283 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15283 |
---|---|
container_issue | 24 |
container_start_page | 15235 |
container_title | Chemical reviews |
container_volume | 116 |
creator | Berthet, Mathéo Cheviet, Thomas Dujardin, Gilles Parrot, Isabelle Martinez, Jean |
description | The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities. |
doi_str_mv | 10.1021/acs.chemrev.6b00543 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03572301v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4290044231</sourcerecordid><originalsourceid>FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</originalsourceid><addsrcrecordid>eNqNkUtrGzEUhUVJqR2nv6AQBrJpFuPoMXdGys6Ypja4pBDvhayHozAeOZJtkv76yrHrQhehq4su3zn3oIPQF4KHBFNyo3Qa6ke7inY3rBcYQ8U-oD4BisuaC3yG-hhjUdK6hh46T-kpPwFo8wn1aCM44Yz10WSawov6FVpvfGdvi1HxM_qdb-3SmuJBK-dCawoXYnEfl6rzulCdKX5Y47XvVFuMcwCfNvH1An10qk3283EO0Pzu23w8KWf336fj0axUgOtNyUBbrSohKnBAOGWNsjVQpiymjTNQYWMIbwwxIoMLwoRy2lTaWE6ccWyArg-2j6qV6-hXKr7KoLycjGZyv8MMGsow2ZHMfj2w6xietzZtZI6qbduqzoZtkvmOEBwY8P9Agda8YTnpAF39gz6Fbcx_8UZVtAIQe0N2oHQMKUXrTmEJlvv6ZK5PHuuTx_qy6vLovV2srDlp_vSVgZsDsFf_vfuO5W_uzKcY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854245598</pqid></control><display><type>article</type><title>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</title><source>ACS Publications</source><source>MEDLINE</source><creator>Berthet, Mathéo ; Cheviet, Thomas ; Dujardin, Gilles ; Parrot, Isabelle ; Martinez, Jean</creator><creatorcontrib>Berthet, Mathéo ; Cheviet, Thomas ; Dujardin, Gilles ; Parrot, Isabelle ; Martinez, Jean</creatorcontrib><description>The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.</description><identifier>ISSN: 0009-2665</identifier><identifier>EISSN: 1520-6890</identifier><identifier>DOI: 10.1021/acs.chemrev.6b00543</identifier><identifier>PMID: 27981833</identifier><identifier>CODEN: CHREAY</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amino acids ; Anti-Infective Agents ; Anti-Infective Agents - chemical synthesis ; Anti-Inflammatory Agents, Non-Steroidal ; Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis ; Antineoplastic Agents ; Antineoplastic Agents - chemical synthesis ; Benzazepines ; Benzazepines - chemical synthesis ; beta-Lactams ; beta-Lactams - chemical synthesis ; Biological activity ; Carbohydrates ; Carbohydrates - chemical synthesis ; Chemical compounds ; Chemical Sciences ; Chemical synthesis ; Cyclization ; Cycloaddition Reaction ; Isoxazoles ; Isoxazoles - chemical synthesis ; Isoxazoles - chemistry ; Isoxazolidines ; Nucleosides ; Nucleosides - chemical synthesis ; Optimization ; Organic chemistry ; Oxazines ; Oxazines - chemical synthesis ; Oxidation-Reduction ; Peptide Nucleic Acids ; Peptide Nucleic Acids - chemical synthesis ; Peptidomimetics ; Peptidomimetics - chemical synthesis ; Pyridones ; Pyridones - chemical synthesis ; Scaffolds ; Steroids ; Synthesis (chemistry)</subject><ispartof>Chemical reviews, 2016-12, Vol.116 (24), p.15235-15283</ispartof><rights>Copyright © 2016 American Chemical Society</rights><rights>Copyright American Chemical Society Dec 28, 2016</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</citedby><cites>FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</cites><orcidid>0000-0002-2820-0384 ; 0000-0003-0734-8109</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.chemrev.6b00543$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.chemrev.6b00543$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27981833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-03572301$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Berthet, Mathéo</creatorcontrib><creatorcontrib>Cheviet, Thomas</creatorcontrib><creatorcontrib>Dujardin, Gilles</creatorcontrib><creatorcontrib>Parrot, Isabelle</creatorcontrib><creatorcontrib>Martinez, Jean</creatorcontrib><title>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</title><title>Chemical reviews</title><addtitle>Chem. Rev</addtitle><description>The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.</description><subject>Amino acids</subject><subject>Anti-Infective Agents</subject><subject>Anti-Infective Agents - chemical synthesis</subject><subject>Anti-Inflammatory Agents, Non-Steroidal</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis</subject><subject>Antineoplastic Agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Benzazepines</subject><subject>Benzazepines - chemical synthesis</subject><subject>beta-Lactams</subject><subject>beta-Lactams - chemical synthesis</subject><subject>Biological activity</subject><subject>Carbohydrates</subject><subject>Carbohydrates - chemical synthesis</subject><subject>Chemical compounds</subject><subject>Chemical Sciences</subject><subject>Chemical synthesis</subject><subject>Cyclization</subject><subject>Cycloaddition Reaction</subject><subject>Isoxazoles</subject><subject>Isoxazoles - chemical synthesis</subject><subject>Isoxazoles - chemistry</subject><subject>Isoxazolidines</subject><subject>Nucleosides</subject><subject>Nucleosides - chemical synthesis</subject><subject>Optimization</subject><subject>Organic chemistry</subject><subject>Oxazines</subject><subject>Oxazines - chemical synthesis</subject><subject>Oxidation-Reduction</subject><subject>Peptide Nucleic Acids</subject><subject>Peptide Nucleic Acids - chemical synthesis</subject><subject>Peptidomimetics</subject><subject>Peptidomimetics - chemical synthesis</subject><subject>Pyridones</subject><subject>Pyridones - chemical synthesis</subject><subject>Scaffolds</subject><subject>Steroids</subject><subject>Synthesis (chemistry)</subject><issn>0009-2665</issn><issn>1520-6890</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtrGzEUhUVJqR2nv6AQBrJpFuPoMXdGys6Ypja4pBDvhayHozAeOZJtkv76yrHrQhehq4su3zn3oIPQF4KHBFNyo3Qa6ke7inY3rBcYQ8U-oD4BisuaC3yG-hhjUdK6hh46T-kpPwFo8wn1aCM44Yz10WSawov6FVpvfGdvi1HxM_qdb-3SmuJBK-dCawoXYnEfl6rzulCdKX5Y47XvVFuMcwCfNvH1An10qk3283EO0Pzu23w8KWf336fj0axUgOtNyUBbrSohKnBAOGWNsjVQpiymjTNQYWMIbwwxIoMLwoRy2lTaWE6ccWyArg-2j6qV6-hXKr7KoLycjGZyv8MMGsow2ZHMfj2w6xietzZtZI6qbduqzoZtkvmOEBwY8P9Agda8YTnpAF39gz6Fbcx_8UZVtAIQe0N2oHQMKUXrTmEJlvv6ZK5PHuuTx_qy6vLovV2srDlp_vSVgZsDsFf_vfuO5W_uzKcY</recordid><startdate>20161228</startdate><enddate>20161228</enddate><creator>Berthet, Mathéo</creator><creator>Cheviet, Thomas</creator><creator>Dujardin, Gilles</creator><creator>Parrot, Isabelle</creator><creator>Martinez, Jean</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7X8</scope><scope>7U5</scope><scope>L7M</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2820-0384</orcidid><orcidid>https://orcid.org/0000-0003-0734-8109</orcidid></search><sort><creationdate>20161228</creationdate><title>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</title><author>Berthet, Mathéo ; Cheviet, Thomas ; Dujardin, Gilles ; Parrot, Isabelle ; Martinez, Jean</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Amino acids</topic><topic>Anti-Infective Agents</topic><topic>Anti-Infective Agents - chemical synthesis</topic><topic>Anti-Inflammatory Agents, Non-Steroidal</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis</topic><topic>Antineoplastic Agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Benzazepines</topic><topic>Benzazepines - chemical synthesis</topic><topic>beta-Lactams</topic><topic>beta-Lactams - chemical synthesis</topic><topic>Biological activity</topic><topic>Carbohydrates</topic><topic>Carbohydrates - chemical synthesis</topic><topic>Chemical compounds</topic><topic>Chemical Sciences</topic><topic>Chemical synthesis</topic><topic>Cyclization</topic><topic>Cycloaddition Reaction</topic><topic>Isoxazoles</topic><topic>Isoxazoles - chemical synthesis</topic><topic>Isoxazoles - chemistry</topic><topic>Isoxazolidines</topic><topic>Nucleosides</topic><topic>Nucleosides - chemical synthesis</topic><topic>Optimization</topic><topic>Organic chemistry</topic><topic>Oxazines</topic><topic>Oxazines - chemical synthesis</topic><topic>Oxidation-Reduction</topic><topic>Peptide Nucleic Acids</topic><topic>Peptide Nucleic Acids - chemical synthesis</topic><topic>Peptidomimetics</topic><topic>Peptidomimetics - chemical synthesis</topic><topic>Pyridones</topic><topic>Pyridones - chemical synthesis</topic><topic>Scaffolds</topic><topic>Steroids</topic><topic>Synthesis (chemistry)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berthet, Mathéo</creatorcontrib><creatorcontrib>Cheviet, Thomas</creatorcontrib><creatorcontrib>Dujardin, Gilles</creatorcontrib><creatorcontrib>Parrot, Isabelle</creatorcontrib><creatorcontrib>Martinez, Jean</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Chemical reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berthet, Mathéo</au><au>Cheviet, Thomas</au><au>Dujardin, Gilles</au><au>Parrot, Isabelle</au><au>Martinez, Jean</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</atitle><jtitle>Chemical reviews</jtitle><addtitle>Chem. Rev</addtitle><date>2016-12-28</date><risdate>2016</risdate><volume>116</volume><issue>24</issue><spage>15235</spage><epage>15283</epage><pages>15235-15283</pages><issn>0009-2665</issn><eissn>1520-6890</eissn><coden>CHREAY</coden><abstract>The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27981833</pmid><doi>10.1021/acs.chemrev.6b00543</doi><tpages>49</tpages><orcidid>https://orcid.org/0000-0002-2820-0384</orcidid><orcidid>https://orcid.org/0000-0003-0734-8109</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-2665 |
ispartof | Chemical reviews, 2016-12, Vol.116 (24), p.15235-15283 |
issn | 0009-2665 1520-6890 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03572301v1 |
source | ACS Publications; MEDLINE |
subjects | Amino acids Anti-Infective Agents Anti-Infective Agents - chemical synthesis Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis Antineoplastic Agents Antineoplastic Agents - chemical synthesis Benzazepines Benzazepines - chemical synthesis beta-Lactams beta-Lactams - chemical synthesis Biological activity Carbohydrates Carbohydrates - chemical synthesis Chemical compounds Chemical Sciences Chemical synthesis Cyclization Cycloaddition Reaction Isoxazoles Isoxazoles - chemical synthesis Isoxazoles - chemistry Isoxazolidines Nucleosides Nucleosides - chemical synthesis Optimization Organic chemistry Oxazines Oxazines - chemical synthesis Oxidation-Reduction Peptide Nucleic Acids Peptide Nucleic Acids - chemical synthesis Peptidomimetics Peptidomimetics - chemical synthesis Pyridones Pyridones - chemical synthesis Scaffolds Steroids Synthesis (chemistry) |
title | Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A53%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isoxazolidine:%20A%20Privileged%20Scaffold%20for%20Organic%20and%20Medicinal%20Chemistry&rft.jtitle=Chemical%20reviews&rft.au=Berthet,%20Mathe%CC%81o&rft.date=2016-12-28&rft.volume=116&rft.issue=24&rft.spage=15235&rft.epage=15283&rft.pages=15235-15283&rft.issn=0009-2665&rft.eissn=1520-6890&rft.coden=CHREAY&rft_id=info:doi/10.1021/acs.chemrev.6b00543&rft_dat=%3Cproquest_hal_p%3E4290044231%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1854245598&rft_id=info:pmid/27981833&rfr_iscdi=true |